Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.595
+0.035 (2.24%)
Jan 23, 2025, 4:00 PM EST - Market closed
Quince Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$9.50
Upside
+495.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +652.35% | Jan 2, 2025 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +464.26% | Dec 18, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +652.35% | Nov 14, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +652.35% | Nov 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +276.18% | Nov 7, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +589.66% | Oct 29, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +652.35% | Oct 22, 2024 |